
Physight identifies patient risk factors from high-resolution acute care physiological signals with AI to better inform clinicians and anticipate adverse outcomes.

Physight identifies patient risk factors from high-resolution acute care physiological signals with AI to better inform clinicians and anticipate adverse outcomes.
Founded: 2024 (Paris, France)
Product: AI to extract patient risk factors from high-resolution acute-care physiological signals
Team size: Approximately 1–10 employees
Notable support: Received non-equity assistance from Agoranov (Mar 1, 2024)
Acute-care clinical monitoring; early detection of patient deterioration
2024
Medtech / Healthcare AI
Non-equity assistance announced March 1, 2024
“AGORANOV (non-equity assistance)”